These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29102659)

  • 1. Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls.
    García-Álvarez L; Caso JR; García-Portilla MP; de la Fuente-Tomás L; González-Blanco L; Sáiz Martínez P; Leza JC; Bobes J
    Eur Psychiatry; 2018 Jan; 47():50-59. PubMed ID: 29102659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder.
    Quidé Y; Bortolasci CC; Spolding B; Kidnapillai S; Watkeys OJ; Cohen-Woods S; Berk M; Carr VJ; Walder K; Green MJ
    Psychol Med; 2019 Dec; 49(16):2736-2744. PubMed ID: 30560764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia.
    Martínez-Gras I; Pérez-Nievas BG; García-Bueno B; Madrigal JL; Andrés-Esteban E; Rodríguez-Jiménez R; Hoenicka J; Palomo T; Rubio G; Leza JC
    Schizophr Res; 2011 May; 128(1-3):15-22. PubMed ID: 21334179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adults with schizophrenia and bipolar diagnoses.
    Aas M; Dieset I; Hope S; Hoseth E; Mørch R; Reponen E; Steen NE; Laskemoen JF; Ueland T; Aukrust P; Agartz I; Andreassen OA; Melle I
    Brain Behav Immun; 2017 Oct; 65():342-349. PubMed ID: 28619247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbial signatures and differences in bipolar disorder and schizophrenia of emerging adulthood.
    Chen YH; Zhou CH; Yu H; Wu WJ; Wang YW; Liu L; Hu GT; Li BJ; Peng ZW; Wang HN
    CNS Neurosci Ther; 2023 Jun; 29 Suppl 1(Suppl 1):5-17. PubMed ID: 36468448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B Cell-activating factor (BAFF): A promising trans-nosographic biomarker of inflammation and autoimmunity in bipolar disorder and schizophrenia.
    Boukouaci W; Lajnef M; Wu CL; Bouassida J; Saitoh K; Sugunasabesan S; Richard JR; Apavou M; Lamy A; Henensal A; Nkam I; Hasty L; Sayous R; Bengoufa D; Barau C; Le Corvoisier P; Honnorat J; Maskos U; Yolken R; Leboyer M; Tamouza R
    Brain Behav Immun; 2024 Oct; 121():178-188. PubMed ID: 39047848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: potential relationship with latent Toxoplasma Gondii infection.
    Hamdani N; Bengoufa D; Godin O; Doukhan R; Le Guen E; Daban-Huard C; Bennabi M; Delavest M; Lépine JP; Boukouaci W; Laouamri H; Houenou J; Jamain S; Richard JR; Lecorvosier P; Yolken R; Rajagopal K; Leboyer M; Tamouza R
    BMC Psychiatry; 2018 Jul; 18(1):239. PubMed ID: 30053866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of peripheral inflammation with body mass index and depressive relapse in bipolar disorder.
    Bond DJ; Andreazza AC; Hughes J; Dhanoa T; Torres IJ; Kozicky JM; Young LT; Lam RW; Yatham LN
    Psychoneuroendocrinology; 2016 Mar; 65():76-83. PubMed ID: 26731572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders.
    Steen NE; Methlie P; Lorentzen S; Dieset I; Aas M; Nerhus M; Haram M; Agartz I; Melle I; Berg JP; Andreassen OA
    J Psychiatr Res; 2014 May; 52():57-62. PubMed ID: 24534618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proton magnetic resonance spectroscopy study in schizoaffective disorder: comparison of bipolar disorder and schizophrenia.
    Kalaycı D; Ozdel O; Sözeri-Varma G; Kıroğlu Y; Tümkaya S
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):176-81. PubMed ID: 22306485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
    Weigelt K; Carvalho LA; Drexhage RC; Wijkhuijs A; de Wit H; van Beveren NJ; Birkenhäger TK; Bergink V; Drexhage HA
    Brain Behav Immun; 2011 Aug; 25(6):1162-9. PubMed ID: 21421043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The severity of inflammation in major neuropsychiatric disorders: comparison of neutrophil-lymphocyte and platelet-lymphocyte ratios between schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and obsessive compulsive disorder.
    Bulut NS; Yorguner N; Çarkaxhiu Bulut G
    Nord J Psychiatry; 2021 Nov; 75(8):624-632. PubMed ID: 34319861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognition in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
    Jiménez-López E; Aparicio AI; Sánchez-Morla EM; Rodriguez-Jimenez R; Vieta E; Santos JL
    J Affect Disord; 2017 Nov; 222():169-176. PubMed ID: 28709024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
    Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
    Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study indicating the dysregulation of the complement and coagulation cascades in treated schizophrenia and bipolar disorder patients.
    Santa Cruz EC; Zandonadi FDS; Fontes W; Sussulini A
    Biochim Biophys Acta Proteins Proteom; 2021 Aug; 1869(8):140657. PubMed ID: 33839315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls.
    Vreeker A; Boks MP; Abramovic L; Verkooijen S; van Bergen AH; Hillegers MH; Spijker AT; Hoencamp E; Regeer EJ; Riemersma-Van der Lek RF; Stevens AW; Schulte PF; Vonk R; Hoekstra R; van Beveren NJ; Kupka RW; Brouwer RM; Bearden CE; MacCabe JH; Ophoff RA;
    Psychol Med; 2016 Mar; 46(4):807-18. PubMed ID: 26621616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial functioning in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
    Jiménez-López E; Sánchez-Morla EM; Aparicio AI; López-Villarreal A; Martínez-Vizcaíno V; Rodriguez-Jimenez R; Vieta E; Santos JL
    J Affect Disord; 2018 Mar; 229():177-185. PubMed ID: 29316520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodevelopmental Versus Neurodegenerative Model of Schizophrenia and Bipolar Disorder: Comparison with Physiological Brain Development and Aging.
    Buoli M; Serati M; Caldiroli A; Cremaschi L; Altamura AC
    Psychiatr Danub; 2017 Mar; 29(1):24-27. PubMed ID: 28291970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia.
    García-Bueno B; Bioque M; Mac-Dowell KS; Barcones MF; Martínez-Cengotitabengoa M; Pina-Camacho L; Rodríguez-Jiménez R; Sáiz PA; Castro C; Lafuente A; Santabárbara J; González-Pinto A; Parellada M; Rubio G; García-Portilla MP; Micó JA; Bernardo M; Leza JC
    Schizophr Bull; 2014 Mar; 40(2):376-87. PubMed ID: 23486748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.